SavedAdd your journal

Journals / Turkish Journal of Cancer / 2001 / Cilt: 31 - Sayı: 2

Radiation recall effect with docetaxel: Is it a barrier for sandwich approach of radiotherapy sequencing in adjuvant breast cancer treatment?

Mustafa SAMUR
Melahat GARİPAĞAOĞLU
Hakan AKBULUT
Pages
82–86
DOI
—
🏛️Bibliographic metadata and full text access for this article are provided via DergiPark.
DergiPark Record ↗
✨

AI Summary & Key Takeaways

AI Insight
⚡ TL;DR(Too Long; Didn't Read)

Here, we report three cases with radiation recall and discuss the phenomenon in the context of taxanes.

📌 3 Key Takeaways

🎯
Objective & Hypothesis:in recent years new developments occurred in adjuvant therapy of breast cancer.
📊
Key Findings & Data:The role of radiotherapy and taxanes increased with the insight of new studies.
💡
Conclusion & Impact:Here, we report three cases with radiation recall and discuss the phenomenon in the context of taxanes.
🔬Design:Research Article
📍Scope:Comprehensive Sample
⚙️Variables:Dermatit · Kemoterapi · adjuvan

Abstract

in recent years new developments occurred in adjuvant therapy of breast cancer. The role of radiotherapy and taxanes increased with the insight of new studies. However, we observed an unexpected high incidence of radiation recall phenomenon with the sandwich approach of administering radiotherapy between anthracyciin based chemotherapy and docetaxel for the patients with more than 3 positive axillary nodes. Here, we report three cases with radiation recall and discuss the phenomenon in the context of taxanes.

Özet

Radiation recall effect with docetaxel: Is it a barrier for sandwich approach of radiotherapy sequencing in adjuvant breast cancer treatment?

🔖

Cite This Article

SAMUR, M., GARİPAĞAOĞLU, M., AKBULUT, H. (2001). Radiation recall effect with docetaxel: Is it a barrier for sandwich approach of radiotherapy sequencing in adjuvant breast cancer treatment?. Turkish Journal of Cancer, Cilt: 31 - Sayı: 2, 82–86. https://ajindex.com/articles/368391

📄 Full Text PDF Viewer

📄

PDF görüntüleyici hazırlanıyor...

References (17)

  1. Overgaard M, Hansen PS, Overgaard J, et al. Postoperative radiotherapy in high-risk premenopausal women with breast cancer who receive adjuvant chemotherapy. Danish Breast Cancer Cooperative Group 82b Trial. N Engl J Med 1997;337:949-55
  2. Ragaz J, Jackson SM, Le N, et al. Adjuvant radiotherapy and chemotherapy in node-positive premenopausal women with breast cancer. N Engl J Med 1997;337:956-62
  3. Henderson IC, Berry D, Demetri G, et al. Improved disease free survival (DFS) and overall survival (OS) from the addition of sequential paclitaxel (T) but not from the escalation of doxorubicin (A) dose level in the adjuvant chemotherapy of patients with node positive primary breast cancer. Proc Am Soc Clin Oncol 1998;17:101a. Abstract 390A
  4. Kellie SJ, Plowman PN, Malpas JS. Radiation recall and radiosensitization with alkylating agents. Lancet 1987;1:1149-50
  5. Fontana JA. Radiation recall associated with VP-16-213 therapy. Cancer Treat Rep 1979;63:224-5
  6. Parry BR. Radiation recall induced by tamoxifen. Lancet 1992;340:49
  7. Perez EA, Campbell DL, Ryu JK. Radiation recall dermatitis induced by edatrexate in a patient with breast cancer. Cancer Invest 1995;13:604-7
  8. Phillips KA, Urch M, Bishop JF. Radiation-recall dermatitis in a patient treated with paclitaxel. J Clin Oncol 1995;13:305
  9. Zulian GB, Aapro MS. Docetaxel and radiation-recall severe mucositis. Ann Oncol 1994;5:964
  10. Shenkier T, Gelmon K. Paclitaxel and radiation-recall dermatitis. J Clin Oncol 1994;12:439
  11. Raghavan VT, Bloomer WD, Merkel DE. Taxol and radiation recall dermatitis. Lancet 1993;341:1354
  12. Yeo W, Leung SF, Johnson PJ. Radiation-recall dermatitis with docetaxel: establishment of a requisite radiation threshold. Eur J Cancer 1997;33:698- 9
  13. Bokemeyer C, Lampe C, Heneka M, et al. Paclitaxel-induced radiation recall dermatitis. Ann Oncol 1996;7:755-6
  14. Milas L, Hunter NR, Mason KA, et al. Enhancement of tumor radioresponse of a murine mammary carcinoma by paclitaxel. Cancer Res 1994;54:3506- 10
  15. Mason KA, Kishi K, Hunter N, et al. Effect of docetaxel on the therapeutic ratio of fractionated radiotherapy in vivo. Clin Cancer Res 1999;5:4191-8
  16. Creane M, Seymour CB, Colucci S, et al. Radiobiological effects of docetaxel (Taxotere): a potential radiation sensitizer. Int J Radiat Biol 1999;75:731-7
  17. Creane M, Seymour CB, Mothersill C. Effect of docetaxel (Taxotere) on expression of radiation-induced lethal mutations in human cell lines. Int J Radi